BackKorro Bio Overview
Korro Bio Inc.

Korro Bio Target Price

See Korro Bio's analyst price targets ($15) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$11.35

Average Target Price

$15.0032.2% upside

1 analysts in the last 4 months

High: $15 | Low: $15

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-19H.C. WainwrightMitchell Kapoor$1532.2% upsideOpen
2026-03-13Cantor FitzgeraldSteve Seehouse$2293.8% upsideOpen
2026-03-13Raymond JamesRyan Deschner$23102.6% upsideOpen
2026-02-18Raymond James$1858.6% upsideOpen
2026-01-29H.C. Wainwright$2076.2% upsideOpen
2026-01-29Chardan Capital$1532.2% upsideOpen
2026-01-28Piper SandlerYasmeen Rahimi$30164.3% upsideOpen
2026-01-28William BlairMyles Minter$1011.9% downsideOpen
2026-01-28Oppenheimer$2293.8% upsideOpen
2026-01-27Cantor FitzgeraldSteve Seedhouse$2185% upsideOpen
2025-04-16Chardan CapitalKeay Nakae$25120.3% upsideOpen
2024-10-21RBC CapitalLuca Issi$105825.1% upsideOpen
2024-05-15BMO CapitalKostas Biliouris$120957.3% upsideOpen
2024-03-28H.C. Wainwright$115913.2% upsideOpen
2024-03-27RBC Capital$90693% upsideOpen

Korro Bio (KRRO) FAQ

Korro Bio (KRRO) currently reports a target price of $15. Use the charts on this page to explore Korro Bio's target price history and peer comparisons.

Analysts' average 12-month price target for Korro Bio is $15, about 32.2% upside from the current share price of $11.35. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $15, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Korro Bio, and consider following KRRO for alerts when major investors trade the stock.

Korro Bio is classified in the Healthcare sector. On target price, it currently shows $15. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRRO with unrelated industries.